Total Payments
$566.64
2024 Payments
$162.18
Companies
19
Transactions
29
Medicare Patients
4,760
Medicare Billing
$694,889
Payment Breakdown by Category
Food & Beverage$566.64 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $566.64 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $96.60 | 4 | $0 (2024) |
| ABBVIE INC. | $57.52 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $55.54 | 3 | $0 (2024) |
| UCB, Inc. | $45.37 | 2 | $0 (2024) |
| ARGENX US, INC. | $34.29 | 1 | $0 (2023) |
| Medtronic, Inc. | $27.52 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $23.73 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $21.72 | 1 | $0 (2021) |
| Celgene Corporation | $21.40 | 1 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $21.02 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $162.18 | 8 | Novartis Pharmaceuticals Corporation ($55.54) |
| 2023 | $101.21 | 5 | ARGENX US, INC. ($34.29) |
| 2022 | $127.74 | 7 | Lundbeck LLC ($43.71) |
| 2021 | $151.78 | 7 | UCB, Inc. ($26.63) |
| 2017 | $23.73 | 2 | Sunovion Pharmaceuticals Inc. ($23.73) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Drug Infusion Systems | ||||||
| 10/08/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neurology | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neurology | ||||||
| 04/30/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Neurology | ||||||
| 04/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.26 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Altea (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: MR - MRI | ||||||
| 04/18/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $12.72 | General |
| 03/30/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/07/2023 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immune | ||||||
| 01/21/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: Immunology | ||||||
| 11/08/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/08/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Neuroscience | ||||||
| 07/08/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/30/2022 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: UPLIZNA | ||||||
| 12/03/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/01/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2021 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $21.72 | General |
| 06/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,109 | 8,609 | $435,377 | $168,241 |
| 2022 | 12 | 1,099 | 8,926 | $410,312 | $166,311 |
| 2021 | 13 | 1,276 | 8,632 | $441,295 | $190,144 |
| 2020 | 14 | 1,276 | 8,351 | $424,665 | $170,192 |
Total Patients
4,760
Total Services
34,518
Medicare Billing
$694,889
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 410 | 534 | $114,276 | $45,155 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 15 | 7,200 | $68,400 | $35,384 | 51.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 181 | 335 | $77,455 | $22,814 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 126 | 126 | $46,242 | $18,371 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 123 | 150 | $45,150 | $17,845 | 39.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 66 | 66 | $30,700 | $10,346 | 33.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 75 | 75 | $28,029 | $9,822 | 35.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 42 | 42 | $11,508 | $3,765 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 70 | $10,570 | $3,732 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,047 | $1,007 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 363 | 457 | $94,738 | $37,124 | 39.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 16 | 7,600 | $72,200 | $37,025 | 51.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 177 | 303 | $66,130 | $22,647 | 34.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 150 | 150 | $53,593 | $21,925 | 40.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 110 | 123 | $36,516 | $15,652 | 42.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 66 | 66 | $28,459 | $10,121 | 35.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 54 | 54 | $18,945 | $6,849 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 81 | $11,520 | $4,275 | 37.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 41 | 43 | $11,786 | $4,201 | 35.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 13 | 14 | $7,609 | $3,054 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,681 | $2,053 | 43.9% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 18 | 18 | $4,135 | $1,385 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 476 | 669 | $113,220 | $55,930 | 49.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 14 | 7,000 | $66,500 | $32,933 | 49.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 197 | 197 | $63,040 | $29,317 | 46.5% |
About Dr. Bart Grelinger, MD
Dr. Bart Grelinger, MD is a Electrodiagnostic Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730184433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bart Grelinger, MD has received a total of $566.64 in payments from pharmaceutical and medical device companies, with $162.18 received in 2024. These payments were reported across 29 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($566.64).
As a Medicare-enrolled provider, Grelinger has provided services to 4,760 Medicare beneficiaries, totaling 34,518 services with total Medicare billing of $694,889. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Clinical Neurophysiology, Neurology
- Location Wichita, KS
- Active Since 06/17/2005
- Last Updated 04/13/2021
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1730184433
Products in Payments
- VYEPTI (Biological) $96.60
- KESIMPTA (Drug) $55.54
- QULIPTA (Drug) $37.30
- VYVGART (Drug) $34.29
- Briviact (Drug) $26.63
- APTIOM (Drug) $23.73
- ZEPOSIA (Drug) $21.40
- NURTEC ODT (Drug) $21.02
- VYALEV (Drug) $20.22
- Omnia (Device) $19.95
- Ocrevus (Biological) $19.54
- BAFIERTAM (Drug) $19.48
- BOTOX (Biological) $19.17
- Rystiggo (Drug) $18.74
- Nourianz (Drug) $18.55
- TYSABRI (Biological) $18.31
- UPLIZNA (Drug) $18.04
- MAGNETOM Altea (Device) $16.17
- SYNCHROMEDII (Device) $15.88
- INTELLIS ADAPTIVESTIM (Device) $11.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Electrodiagnostic Medicine Doctors in Wichita
Dr. Gautham Reddy, Md, MD
Electrodiagnostic Medicine — Payments: $1,118
Electrodiagnostic Medicine $1,118
Dr. Paul Genilo, Md, MD
Electrodiagnostic Medicine — Payments: $701.07
Electrodiagnostic Medicine $701.07
Dr. Ty Schwertfeger, Md, MD
Electrodiagnostic Medicine — Payments: $558.24
Electrodiagnostic Medicine $558.24